Modulation of PI3K / AKT / mTOR and apoptosis pathway in colon cancer cells by the plant flavonoid fisetin
PeerJ · 2025
DOI: 10.7717/peerj.20225 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Amal Alamoudi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, College of Sciences, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Apoptosis, Proto-Oncogene Proteins c-akt, Flavonoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University, Riyadh, Saudi Arabia.
Abstract (Originalsprache)
Colorectal cancer (CRC) is a complex multifactorial disease caused by genetic and epigenetic changes playing a vital role in its development and progression. Chemotherapy remains a major option in the treatment of CRC. However, due to its unintended effects on normal tissue, research on identifying plant-based therapeutic agents as an alternative treatment modality has gained attention. Fisetin, a plant-derived flavonoid, has shown promising effects as an anticancer agent against several human cancers, including colon cancer. However, there is limited research focusing on studying the mechanism of action of fisetin. The PI3K / AKT / mTOR pathway as a key regulator of cancer cells has become a promising target for potential anti-cancer development. This study examined the anti-cancer effects of fisetin, emphasizing its effects on the PI3K / AKT / mTOR and apoptosis pathways in human colon cancer Caco-2 cells. The Caco-2 cells were treated with different concentrations (15, 30, 60, 90, or 120 µM) of fisetin for 12 or 24 h. Cell viability was evaluated using the MTT assay, while the expressions of PI3K / AKT / mTOR pathway genes and apoptosis genes, BAX and BCL-2 , were analyzed by qRT-PCR. Fisetin markedly decreased the cell viability in a dose- and time-dependent manner. Fisetin down-regulated BCL-2 , PI3K , mTOR , and NF - κB gene expression while up-regulating BAX gene expression. This suggested the inhibition of PI3K / AKT / mTOR pathway and induction of apoptosis. GeneMANIA and OncoDB further corroborated these results. These data demonstrate that the antiproliferative effects of fisetin were medicated through the modulation of PI3K / AKT / mTOR and apoptosis pathway. Thus, the study underscores fisetin’s potential as a cancer-preventative drug against cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry Department, College of Sciences, King Saud University, Riyadh, Saudi Arabia.
Förderung
- King Saud University, Riyadh, Saudi Arabia
Zitieren
APA
Alamoudi, A., Alqarni, K., Khayyat, A. I. A., Hussain, T., & Alamery, S. (2025). Modulation of PI3K / AKT / mTOR and apoptosis pathway in colon cancer cells by the plant flavonoid fisetin. PeerJ. https://doi.org/10.7717/peerj.20225
Vancouver
Alamoudi A, Alqarni K, Khayyat AIA, Hussain T, Alamery S. Modulation of PI3K / AKT / mTOR and apoptosis pathway in colon cancer cells by the plant flavonoid fisetin. PeerJ. 2025. doi:10.7717/peerj.20225
BibTeX
@article{Alamoudi2025,
author = {Alamoudi, Amal and Alqarni, Khlood and Khayyat, Arwa Ishaq A and Hussain, Tajamul and Alamery, Salman},
title = {Modulation of PI3K / AKT / mTOR and apoptosis pathway in colon cancer cells by the plant flavonoid fisetin},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.20225}
}
EUVIMED